{
  "actions": [
    {
      "acted_at": "2005-05-24", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2005-06-17", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2600-109", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "109", 
  "cosponsors": [
    {
      "district": "5", 
      "name": "Brown-Waite, Ginny", 
      "sponsored_at": "2005-06-08", 
      "state": "FL", 
      "thomas_id": "01713", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "29", 
      "name": "Kuhl, John R. \"Randy\", Jr.", 
      "sponsored_at": "2005-05-26", 
      "state": "NY", 
      "thomas_id": "01795", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "3", 
      "name": "Lungren, Daniel E.", 
      "sponsored_at": "2005-07-14", 
      "state": "CA", 
      "thomas_id": "00717", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "11", 
      "name": "Owens, Major R.", 
      "sponsored_at": "2005-05-26", 
      "state": "NY", 
      "thomas_id": "00883", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "12", 
      "name": "Putnam, Adam H.", 
      "sponsored_at": "2005-06-17", 
      "state": "FL", 
      "thomas_id": "01645", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2005-05-24", 
  "number": "2600", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale or trade of prescription drugs that were knowingly caused to be adulterated or misbranded, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Prescription Drug Tampering Prevention Act of 2005", 
  "sponsor": {
    "district": "22", 
    "name": "Shaw, E. Clay, Jr.", 
    "state": "FL", 
    "thomas_id": "01047", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2005-05-24", 
  "subjects": [
    "Commerce", 
    "Crime and law enforcement", 
    "Drug adulteration", 
    "Drugs", 
    "Fines (Penalties)", 
    "Fraud", 
    "Health", 
    "Labeling", 
    "Sentences (Criminal procedure)"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2005-05-24", 
    "text": "Prescription Drug Tampering Prevention Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to establish criminal penalties of a fine or imprisonment for any term of years or for life, or both, for: (1) knowingly causing a prescription drug to be adulterated or misbranded and selling or trading the drug; or (2) purchasing or trading for a prescription drug knowing or having reason to know that the drug was knowingly caused to be adulterated or misbranded. Modifies provisions pertaining to criminal fines for committing certain prohibited acts involving food, drugs, devices, or cosmetics."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug Tampering Prevention Act of 2005", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale or trade of prescription drugs that were knowingly caused to be adulterated or misbranded, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T19:27:11-04:00"
}